Paricalcitol
A vitamin D analogue.
Brand name: Zemplar.
In 1998 paricalcitol was approved by the FDA for the treatment of hyperparathyroidism due to chronic renal failure.
It causes less elevation of calcium than calcitriol, another vitamin D analogue and is associated with a lower mortality rate than calcitriol in patients on long-term dialysis